STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
124
13F, latest reported quarter
What the filings say about INVX
Insiders, 180 days
-$287.7M net sold
3 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$300.0K
1 notice
Innovex International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Innovex International, Inc. insiders sold a net $287.7M of stock across 31 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 28.2% of the 13,164,573 shares held after it.
2 other insiders sold within 30 days.
124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Amberjack Capital Partners, L.P. sold about $106.4M of INVX on Aug 10, 2026; 2 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 28.2% of the 3,073,822 shares held after it.
2 other insiders sold within 30 days.
124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Amberjack Capital Partners, L.P. sold about $24.8M of INVX on Aug 10, 2026; 2 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 28.2% of the 728,498 shares held after it.
2 other insiders sold within 30 days.
124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Amberjack Capital Partners, L.P. sold about $5.9M of INVX on Aug 10, 2026; 2 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 28.2% of the 628,411 shares held after it.
2 other insiders sold within 30 days.
124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Amberjack Capital Partners, L.P. sold about $5.1M of INVX on Aug 10, 2026; 2 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 28.3% of the 311 shares held after it.
2 other insiders sold within 30 days.
124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Amberjack Capital Partners, L.P. sold about $2.5K of INVX on Aug 10, 2026; 2 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
31 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
INVX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Reddout Mark
Filed 2026-08-04
$300.0K
INVX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco Oil & Gas Services ETF
$1.7M position · as of 2026-07-31
2.7%
Brandes U.S. Small-Mid Cap Value ETF
$4.3M position · as of 2026-06-30
2.6%
Brandes Small Cap Value Fund
$16.2M position · as of 2026-06-30
2.5%
State Street(R) SPDR(R) S&P(R) Oil & Gas Equipment & Services ETF
$7.4M position · as of 2026-06-30
1.6%
OIL & GAS EQUIPMENT & SERVICES ULTRASECTOR PROFUND
$160.4K position · as of 2026-07-31
1.4%
M3Sixty Small Cap Growth Fund
$127.6K position · as of 2026-05-31
1.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.3M
$4.0M
$1.6M
-26%
+85%
2024
$9.1M
$7.7M
$2.6M
-53%
+76%
2023
$3.7M
$2.0M
$1.5M
-21%
+101%
2022
$4.1M
$3.2M
$2.3M
-8%
+97%
2021
$6.1M
-$165.9K
$1.7M
-34%
+20%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $287.7M sold by insiders over 180 days, 124 funds added last quarter, $300.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt INVX
FY Dec 2025
10.09x
FY Dec 2024
3.67x
FY Dec 2023
1.87x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
8.27x
Mar 2026
9.96x
Dec 2025
10.09x
Sep 2025
8.71x
Jun 2025
4.27x
Mar 2025
5.69x
Dec 2024
3.67x
Sep 2024
6.35x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+6.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity INVX
FY Dec 2025
+8.3%
FY Dec 2024
+21.8%
FY Dec 2023
n/a
FY Dec 2022
+29.3%
FY Dec 2021
-21.0%
Jun 2026
+6.0%
Mar 2026
+5.2%
Dec 2025
+8.3%
Sep 2025
+10.4%
Jun 2025
+21.4%
Mar 2025
+21.0%
Dec 2024
+21.8%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets INVX
FY Dec 2025
+6.8%
FY Dec 2024
+16.8%
FY Dec 2023
n/a
FY Dec 2022
+6.4%
FY Dec 2021
-11.9%
Jun 2026
+4.8%
Mar 2026
+4.2%
Dec 2025
+6.8%
Sep 2025
+8.5%
Jun 2025
+12.9%
Mar 2025
+12.5%
Dec 2024
+16.8%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+7.5%
operating income after a 37.7% effective tax rate, over long-term debt only, 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital INVX
FY Dec 2025
+10.5%
FY Dec 2024
+10.5%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+7.5%
Mar 2026
+6.6%
Dec 2025
+10.5%
Sep 2025
+13.4%
Jun 2025
+11.2%
Mar 2025
+10.1%
Dec 2024
+10.5%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+8.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed INVX
FY Dec 2025
+12.3%
FY Dec 2024
+6.9%
FY Dec 2023
n/a
FY Dec 2022
+8.4%
FY Dec 2021
-12.6%
Jun 2026
+8.9%
Mar 2026
+8.1%
Dec 2025
+12.3%
Sep 2025
+13.0%
Jun 2025
+5.9%
Mar 2025
+5.0%
Dec 2024
+6.9%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
34.45x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing INVX
FY Dec 2025
18.23x
FY Dec 2024
5.61x
FY Dec 2023
19.23x
FY Dec 2022
13.52x
FY Dec 2021
n/a
Jun 2026
27.87x
Mar 2026
32.52x
Dec 2025
18.23x
Sep 2025
26.87x
Jun 2025
7.40x
Mar 2025
8.20x
Dec 2024
5.61x
Sep 2024
4.37x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.0B
market value at close 2026-10-26 on 2026-07-29 shares, plus long-term debt only, 2026-06-30, minus cash 2024-06-30
Enterprise value INVX
FY Dec 2025
$1.3B
FY Dec 2024
$779.2M
FY Dec 2023
$648.7M
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$1.5B
Mar 2026
$1.5B
Dec 2025
$1.3B
Sep 2025
$1.1B
Jun 2025
$926.6M
Mar 2025
$1.1B
Dec 2024
$779.2M
Sep 2024
$332.5M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.0%
TTM free cash flow over market value at close 2026-10-26
FCF yield INVX
FY Dec 2025
+10.8%
FY Dec 2024
+7.0%
FY Dec 2023
+5.4%
FY Dec 2022
-2.7%
FY Dec 2021
+4.1%
Jun 2026
+7.6%
Mar 2026
+9.0%
Dec 2025
+10.8%
Sep 2025
+11.5%
Jun 2025
+11.2%
Mar 2025
+6.8%
Dec 2024
+7.0%
Sep 2024
+10.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -58%, PEG needs growth
PEG, trailing INVX
FY Dec 2025
n/a
FY Dec 2024
0.05x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
0.53x
Mar 2025
0.25x
Dec 2024
0.05x
Sep 2024
0.18x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
INVX ranks highest on financial health (93rd percentile) and risk and compliance (62nd), and lowest on insider conviction (1st), among Industrials peers.
Profitability
45
Inputs
Return on equity+6.0% · 40 pct, sector of 198
Return on assets+4.8% · 56 pct, sector of 224
Return on invested capital+7.5% · 26 pct, sector of 107
Return on capital employed+8.9% · 57 pct, sector of 195
Financial health
93
Inputs
Debt to equity0.02x · 87 pct, sector of 214
Cash flow to debt8.27x · 98 pct, sector of 173
Growth
47
Inputs
Revenue growth, YoY+48.0% · 94 pct, sector of 254
Backlog growth, YoY-94.3% · 0 pct, sector of 89
Insider conviction
1
Inputs
Net Form 4 buying (codes P and S), 180d-$287.7M · 3 pct, sector of 170
Insider buyers, 180d0 · 0 pct, sector of 172
Institutional and government
43
Inputs
Funds adding, latest quarter124 · 43 pct, sector of 201
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
62
Inputs
Short interest, % of float+5.9% · 35 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+10.9% · 50 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
INVX filings, in plain words
Are Innovex International insiders buying or selling INVX?
In the 180 days to 2026-10-28, Innovex International insiders were net sellers, a net $287.7M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of INVX?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $300.0K of stock; the latest, by Reddout Mark, was filed 2026-08-04.
Read the full summary
In the 180 days to 2026-10-28, Innovex International insiders were net sellers of INVX, a net $287.7M across purchases and sales reported on Form 4 by 3 sellers. Most of that figure, $287.1M, came from a holder of 10% or more rather than an officer or director. None of the 14 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $300.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.